Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Universität Heidelberg, Dissertation, 2022
- Keyword
-
Proteolysis
Examinations
Evaluation
PROTAC
Targeted protein degradation
Proteasomal degradation
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (who)
-
Universitätsbibliothek Heidelberg
- (when)
-
2022
- Creator
- Contributor
- DOI
-
10.11588/heidok.00031644
- URN
-
urn:nbn:de:bsz:16-heidok-316445
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gama Brambila, Rodrigo
- Wölfl, Stefan
- Universitätsbibliothek Heidelberg
Time of origin
- 2022
Other Objects (12)
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) **
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) **
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10